Brief: Coherus Biosciences Announces CFO Transition Plans
Dec 7 (Reuters) - Coherus BioSciences Inc CHRS.O :
* COHERUS BIOSCIENCES ANNOUNCES CFO TRANSITION PLANS
* COHERUS BIOSCIENCES INC - WILL APPOINT A NEW INTERIM
PRINCIPAL
FINANCIAL OFFICER IN LATE DECEMBER 2023 OR EARLY JANUARY 2024
Source text for Eikon: ID:nGNX9TQ56L
Further company coverage: CHRS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Coherus Oncology
See all newsBrief: Coherus Oncology Initiates Process To Sell Legacy Biosim Assets
Brief: Coherus Oncology Announces Special Dividend Of Biosimilar Contingent Value Rights
Coherus Oncology Inc reports results for the quarter ended June 30 - Earnings Summary
Coherus Oncology Q2 revenue rises 40% on higher LOQTORZI volume, but slightly falls below estimates
Brief: Coherus Oncology Q2 Net Income USD -20.631 Million